US Broker Ratings

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring the 14.25% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking exposure to..

Cytokinetics, Incorporated (CYTK): Investor Outlook with a 118.79% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK) is garnering significant attention in the biotechnology sector, not only for its innovative drug development pipeline but also for its compelling potential..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unpacking the 90% Revenue Growth in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has been capturing investor attention with its remarkable 90.4% revenue growth. Specializing in the..

TransMedics Group, Inc. (TMDX): Analyzing the Growth Potential in Medical Devices

TransMedics Group, Inc. (TMDX), a pioneering force in the healthcare sector, is making waves with its innovative approach to organ transplant therapy. As a commercial-stage medical..

Legend Biotech (LEGN) Stock Analysis: A Biotech Powerhouse with 120% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the healthcare sector specializing in biotechnology, is capturing investor attention with its innovative approach to cancer treatment...

Grifols, S.A. (GRFS) Stock Analysis: Unlocking a 37.53% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) stands out in the healthcare sector with its robust portfolio in the plasma therapeutics market. With a market capitalization of $7.39 billion,..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Signal a 16% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a leader in the healthcare information services sector, is capturing the interest of investors with its promising outlook. Based in Draper, Utah,..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech Play with 33% Potential Upside

For investors seeking opportunities in the biotech sector, Soleno Therapeutics, Inc. (NASDAQ: SLNO) offers a compelling proposition. Headquartered in Redwood City, California, Soleno is a clinical-stage..

Akero Therapeutics, Inc. (AKRO): Investor Outlook on a Promising Biotech with a 35.79% Upside Potential

Akero Therapeutics, Inc. (NASDAQ: AKRO) is making waves in the biotechnology sector with its pioneering approach to tackling metabolic diseases, notably through its lead candidate, efruxifermin..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a Biotech with 180% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has captured the attention of the investment community with its promising pipeline in the biotechnology sector, targeting rare genetic disorders. Despite..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 75% Potential Upside in the Biotechnology Sector

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has been on the radar of investors and analysts alike, given its significant role in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking a 28.33% Potential Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the competitive biotechnology sector, offering a compelling investment narrative with its innovative approach to drug delivery and a..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Current Valuations Amid Growth Challenges

Henry Schein, Inc. (HSIC), a prominent player in the healthcare sector, is a leading distributor of healthcare products and services, primarily catering to office-based dental and..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth with a 42% Revenue Surge Amidst Mixed Analyst Ratings

Oscar Health, Inc. (NYSE: OSCR), a pioneering healthcare technology firm, is making waves in the healthcare plans sector with its robust revenue growth. Investors are keenly..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 15% Potential Upside

Bausch + Lomb Corporation (BLCO), a prominent player in the healthcare sector, is renowned for its strong presence in the medical instruments and supplies industry. With..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 27.83% Potential Upside with Solid Revenue Growth

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, stands as a compelling investment opportunity with a market capitalization of $11.48 billion...

Avidity Biosciences, Inc. (RNA) Investor Outlook: Navigating the 131% Upside Potential

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with a potential upside of 131.61%, making it a compelling candidate in the biotechnology sector...

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a Robust 47.75% Potential Upside for Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a cutting-edge player in the biotechnology sector, is capturing investor attention with its impressive trajectory in genetic medicines. Based in Pittsburgh,..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech Contender with a Promising 286% Upside

Vaxcyte, Inc. (PCVX), a clinical-stage biotech company based in San Carlos, California, is setting the stage for significant market interest with a robust pipeline focused on..

Alkermes plc (ALKS) Stock Analysis: Potential 42% Upside Amidst Strategic Developments

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, stands at the forefront of the biopharmaceutical industry, specifically within the specialties of drug manufacturing for both generic..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds